Adult neurogenesis:a real hope or a delusion?Ghulam Hussain,Rabia Akram,Haseeb Anwar,Faiqa Sajid,Tehreem Iman,Hyung Soo Han,Chand Raza,Jose-Luis Gonzalez De Aguilar6-15
Type-B monoamine oxidase inhibitors in neurological diseases:clinical applications based on preclinical findingsMarika Alborghetti,Edoardo Bianchini,Lanfranco De Carolis,Silvia Galli,Francesco E.Pontieri,Domiziana Rinaldi16-21
The future of artificial hibernation medicine:protection of nerves and organs after spinal cord injuryCaiyun Liu,Haixin Yu,Zhengchao Li,Shulian Chen,Xiaoyin Li,Xuyi Chen,Bo Chen22-28
Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?Marta Zagrebelsky,Martin Korte29-34
Pharmacological interventions targeting the microcirculation following traumatic spinal cord injuryRongrong Wang,Jinzhu Bai35-42
Metabolic and proteostatic differences in quiescent and active neural stem cellsJiacheng Yu,Gang Chen,Hua Zhu,Yi Zhong,Zhenxing Yang,Zhihong Jian,Xiaoxing Xiong43-48
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestorationYe Xiong,Asim Mahmood,Michael Chopp49-54
Pathological and therapeutic effects of extracellular vesicles in neurological and neurodegenerative diseasesPaula Izquierdo-Altarejos,Victoria Moreno-Manzano,Vicente Felipo55-61
Emergence of taurine as a therapeutic agent for neurological disordersAshok Jangra,Priyanka Gola,Jiten Singh,Pooja Gond,Swarnabha Ghosh,Mahesh Rachamalla,Abhijit Dey,Danish Iqbal,Mehnaz Kamal,Punya Sachdeva,Saurabh Kumar Jha,Shreesh Ojha,Dinesh Kumar,Niraj Kumar Jha,Hitesh Chopra,Shing Cheng Tan62-68